Omission of lymphadenectomy is possible for low-risk corpus cancer.
Identifieur interne : 007172 ( Main/Curation ); précédent : 007171; suivant : 007173Omission of lymphadenectomy is possible for low-risk corpus cancer.
Auteurs : T. Hidaka [Japon] ; K. Kato ; R. Yonezawa ; T. Shima ; A. Nakashima ; K. Nagira ; T. Nakamura ; S. SaitoSource :
- European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [ 0748-7983 ] ; 2007.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Carcinome endométrioïde (), Carcinome endométrioïde (anatomopathologie), Carcinome endométrioïde (mortalité), Femelle, Humains, Lymphadénectomie (), Métastase lymphatique, Pronostic, Stade de la tumeur, Sujet âgé, Taux de survie, Tumeurs de l'endomètre (), Tumeurs de l'endomètre (anatomopathologie), Tumeurs de l'endomètre (mortalité), Études de suivi, Études rétrospectives.
- MESH :
- anatomopathologie : Carcinome endométrioïde, Tumeurs de l'endomètre.
- mortalité : Carcinome endométrioïde, Tumeurs de l'endomètre.
- Adulte, Adulte d'âge moyen, Carcinome endométrioïde, Femelle, Humains, Lymphadénectomie, Métastase lymphatique, Pronostic, Stade de la tumeur, Sujet âgé, Taux de survie, Tumeurs de l'endomètre, Études de suivi, Études rétrospectives.
English descriptors
- KwdEn :
- Adult, Aged, Carcinoma, Endometrioid (mortality), Carcinoma, Endometrioid (pathology), Carcinoma, Endometrioid (surgery), Endometrial Neoplasms (mortality), Endometrial Neoplasms (pathology), Endometrial Neoplasms (surgery), Female, Follow-Up Studies, Humans, Lymph Node Excision (contraindications), Lymphatic Metastasis, Middle Aged, Neoplasm Staging, Prognosis, Retrospective Studies, Survival Rate.
- MESH :
- contraindications : Lymph Node Excision.
- mortality : Carcinoma, Endometrioid, Endometrial Neoplasms.
- pathology : Carcinoma, Endometrioid, Endometrial Neoplasms.
- surgery : Carcinoma, Endometrioid, Endometrial Neoplasms.
- Adult, Aged, Female, Follow-Up Studies, Humans, Lymphatic Metastasis, Middle Aged, Neoplasm Staging, Prognosis, Retrospective Studies, Survival Rate.
Abstract
The objective of this study is to ascertain whether omission of lymphadenectomy is possible when endometrial cancer is considered low-risk based on intraoperative pathologic indicators.
DOI: 10.1016/j.ejso.2006.09.035
PubMed: 17095180
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003829
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :003829
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :003829
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :002476
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :002476
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002476
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :007302
Links to Exploration step
pubmed:17095180Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Omission of lymphadenectomy is possible for low-risk corpus cancer.</title><author><name sortKey="Hidaka, T" sort="Hidaka, T" uniqKey="Hidaka T" first="T" last="Hidaka">T. Hidaka</name><affiliation wicri:level="1"><nlm:affiliation>Department of Obstetrics and Gynecology, Faculty of Medicine, University of Toyama, 2630, Sugitani, Toyama-shi, Toyama 930-0194, Japan. hidaka@med.u-toyama.ac.jp</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Obstetrics and Gynecology, Faculty of Medicine, University of Toyama, 2630, Sugitani, Toyama-shi, Toyama 930-0194</wicri:regionArea><wicri:noRegion>Toyama 930-0194</wicri:noRegion></affiliation></author><author><name sortKey="Kato, K" sort="Kato, K" uniqKey="Kato K" first="K" last="Kato">K. Kato</name></author><author><name sortKey="Yonezawa, R" sort="Yonezawa, R" uniqKey="Yonezawa R" first="R" last="Yonezawa">R. Yonezawa</name></author><author><name sortKey="Shima, T" sort="Shima, T" uniqKey="Shima T" first="T" last="Shima">T. Shima</name></author><author><name sortKey="Nakashima, A" sort="Nakashima, A" uniqKey="Nakashima A" first="A" last="Nakashima">A. Nakashima</name></author><author><name sortKey="Nagira, K" sort="Nagira, K" uniqKey="Nagira K" first="K" last="Nagira">K. Nagira</name></author><author><name sortKey="Nakamura, T" sort="Nakamura, T" uniqKey="Nakamura T" first="T" last="Nakamura">T. Nakamura</name></author><author><name sortKey="Saito, S" sort="Saito, S" uniqKey="Saito S" first="S" last="Saito">S. Saito</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2007">2007</date><idno type="RBID">pubmed:17095180</idno><idno type="pmid">17095180</idno><idno type="doi">10.1016/j.ejso.2006.09.035</idno><idno type="wicri:Area/PubMed/Corpus">003829</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003829</idno><idno type="wicri:Area/PubMed/Curation">003829</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003829</idno><idno type="wicri:Area/PubMed/Checkpoint">003829</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003829</idno><idno type="wicri:Area/Ncbi/Merge">002476</idno><idno type="wicri:Area/Ncbi/Curation">002476</idno><idno type="wicri:Area/Ncbi/Checkpoint">002476</idno><idno type="wicri:doubleKey">0748-7983:2007:Hidaka T:omission:of:lymphadenectomy</idno><idno type="wicri:Area/Main/Merge">007302</idno><idno type="wicri:Area/Main/Curation">007172</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Omission of lymphadenectomy is possible for low-risk corpus cancer.</title><author><name sortKey="Hidaka, T" sort="Hidaka, T" uniqKey="Hidaka T" first="T" last="Hidaka">T. Hidaka</name><affiliation wicri:level="1"><nlm:affiliation>Department of Obstetrics and Gynecology, Faculty of Medicine, University of Toyama, 2630, Sugitani, Toyama-shi, Toyama 930-0194, Japan. hidaka@med.u-toyama.ac.jp</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Obstetrics and Gynecology, Faculty of Medicine, University of Toyama, 2630, Sugitani, Toyama-shi, Toyama 930-0194</wicri:regionArea><wicri:noRegion>Toyama 930-0194</wicri:noRegion></affiliation></author><author><name sortKey="Kato, K" sort="Kato, K" uniqKey="Kato K" first="K" last="Kato">K. Kato</name></author><author><name sortKey="Yonezawa, R" sort="Yonezawa, R" uniqKey="Yonezawa R" first="R" last="Yonezawa">R. Yonezawa</name></author><author><name sortKey="Shima, T" sort="Shima, T" uniqKey="Shima T" first="T" last="Shima">T. Shima</name></author><author><name sortKey="Nakashima, A" sort="Nakashima, A" uniqKey="Nakashima A" first="A" last="Nakashima">A. Nakashima</name></author><author><name sortKey="Nagira, K" sort="Nagira, K" uniqKey="Nagira K" first="K" last="Nagira">K. Nagira</name></author><author><name sortKey="Nakamura, T" sort="Nakamura, T" uniqKey="Nakamura T" first="T" last="Nakamura">T. Nakamura</name></author><author><name sortKey="Saito, S" sort="Saito, S" uniqKey="Saito S" first="S" last="Saito">S. Saito</name></author></analytic><series><title level="j">European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</title><idno type="ISSN">0748-7983</idno><imprint><date when="2007" type="published">2007</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Carcinoma, Endometrioid (mortality)</term><term>Carcinoma, Endometrioid (pathology)</term><term>Carcinoma, Endometrioid (surgery)</term><term>Endometrial Neoplasms (mortality)</term><term>Endometrial Neoplasms (pathology)</term><term>Endometrial Neoplasms (surgery)</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Lymph Node Excision (contraindications)</term><term>Lymphatic Metastasis</term><term>Middle Aged</term><term>Neoplasm Staging</term><term>Prognosis</term><term>Retrospective Studies</term><term>Survival Rate</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Carcinome endométrioïde ()</term><term>Carcinome endométrioïde (anatomopathologie)</term><term>Carcinome endométrioïde (mortalité)</term><term>Femelle</term><term>Humains</term><term>Lymphadénectomie ()</term><term>Métastase lymphatique</term><term>Pronostic</term><term>Stade de la tumeur</term><term>Sujet âgé</term><term>Taux de survie</term><term>Tumeurs de l'endomètre ()</term><term>Tumeurs de l'endomètre (anatomopathologie)</term><term>Tumeurs de l'endomètre (mortalité)</term><term>Études de suivi</term><term>Études rétrospectives</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Carcinome endométrioïde</term><term>Tumeurs de l'endomètre</term></keywords><keywords scheme="MESH" qualifier="contraindications" xml:lang="en"><term>Lymph Node Excision</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Carcinoma, Endometrioid</term><term>Endometrial Neoplasms</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Carcinome endométrioïde</term><term>Tumeurs de l'endomètre</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Carcinoma, Endometrioid</term><term>Endometrial Neoplasms</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Carcinoma, Endometrioid</term><term>Endometrial Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Lymphatic Metastasis</term><term>Middle Aged</term><term>Neoplasm Staging</term><term>Prognosis</term><term>Retrospective Studies</term><term>Survival Rate</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Carcinome endométrioïde</term><term>Femelle</term><term>Humains</term><term>Lymphadénectomie</term><term>Métastase lymphatique</term><term>Pronostic</term><term>Stade de la tumeur</term><term>Sujet âgé</term><term>Taux de survie</term><term>Tumeurs de l'endomètre</term><term>Études de suivi</term><term>Études rétrospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The objective of this study is to ascertain whether omission of lymphadenectomy is possible when endometrial cancer is considered low-risk based on intraoperative pathologic indicators.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 007172 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 007172 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Curation
|type= RBID
|clé= pubmed:17095180
|texte= Omission of lymphadenectomy is possible for low-risk corpus cancer.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i -Sk "pubmed:17095180" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |